Expression profiling reveals specific gene expression signatures in gastric MALT lymphomas

References

• Wundisch T, Kim T D, Thiede C, Morgner A, Alpen B, Stolte M, et al. Etiology and therapy of Helicobacter pylori-associated gastric lymphomas. Ann Hematol 2003; 82: 535–545
   PubMed Web of Science ®Google Scholar
• Stolte M. Helicobacter pylori gastritis and gastric MALT-lymphoma. Lancet 1992; 339: 745–774
   PubMed Web of Science ®Google Scholar
• Wotherspoon A C, Doglioni C, Diss T C, Pan L, Moschini A, de Boni M, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575–577
   PubMed Web of Science ®Google Scholar
• Du M Q, Isaccson P G. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol 2002; 3: 97–104
   PubMed Web of Science ®Google Scholar
• Fischbach W, Goebeler-Kolve M E, Dragosics B, Greiner A, Stolte M. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 2004; 53: 34–37
   PubMed Web of Science ®Google Scholar
• Wundisch T, Thiede C, Morgner A, Dempfle A, Gunther A, Liu H, et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 2005
   PubMed Web of Science ®Google Scholar
• Montalban C, Santon A, Redondo C, Garcia-Cosio M, Boixeda D, Vazquez-Sequeiros E, et al. Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study. Ann Oncol 2005; 16: 1539–1544
   PubMed Web of Science ®Google Scholar
• Franceschi F, Genta R M, Sepulveda A R. Gastric mucosa: long-term outcome after cure of Helicobacter pylori infection. J Gastroenterol 2002; 37: 17–23
   PubMed Web of Science ®Google Scholar
• Cavalli F, Isaacson P G, Gascoyne R D, Zucca E. MALT Lymphomas. Hematology (Am Soc Hematol Educ Program) 2001; 241–258
   PubMedGoogle Scholar
• Liu H, Ye H, Dogan A, Ranaldi R, Hamoudi A, Bearzi I, et al. T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood. 2001; 98: 1182–1187
   Google Scholar
• Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, Ye H, Molina T, Bouhnik Y, et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 2001; 357: 39–40
   PubMed Web of Science ®Google Scholar
• Murga Penas E M, Hinz K, Roser K, Copie-Bergman C, Wlodarska I, Marynen P, et al. Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas. Leukemia 2003; 17: 2225–2229
   PubMed Web of Science ®Google Scholar
• Dierlamm J, Baens M, Wlodarska I, Stefanova-Ouzounova M, Hernandez J M, Hossfeld D K, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21)p6ssociated with mucosa-associated lymphoid tissue lymphomas. Blood 1999; 93: 3601–3609
   PubMed Web of Science ®Google Scholar
• Willis T G, Jadayel D M, Du M Q, Peng H, Perry A R, Abdul-Rauf M, et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999; 96: 35–45
   PubMed Web of Science ®Google Scholar
• Zhou H, Du M Q, Dixit V M. Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. Cancer Cell 2005; 7: 425–431
   PubMed Web of Science ®Google Scholar
• Ho L, Davis R E, Conne B, Chappuis R, Berczy M, Mhawech P, et al. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells. Blood 2005; 105: 2891–2899
   PubMed Web of Science ®Google Scholar
• Alpen B, Neubauer A, Dierlamm J, Marynen P, Thiede C, Bayerdorfer E, et al. Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection. Blood 2000; 95: 4014–4015
   PubMed Web of Science ®Google Scholar
• Dixon M F, Genta R M, Yardley J H, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161–1181
   PubMed Web of Science ®Google Scholar
• Yang Y H, Dudoit S, Luu P, Lin D M, Peng V, Ngai J, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002; 30: e15
   PubMed Web of Science ®Google Scholar
• Westfall P H, Young S S. Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment. Wiley, New York 1993
   Google Scholar
• Sturn A, Quackenbush J, Trajanoski Z. Genesis: cluster analysis of microarray data. Bioinformatics 2002; 18: 207–208
   PubMed Web of Science ®Google Scholar
• Dennis G, Jr, Sherman B T, Hosack D A, Yang J, Gao W, Lane H C, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003; 4: P3
   PubMed Web of Science ®Google Scholar
• Weil R, Israel A. T-cell-receptor- and B-cell-receptor-mediated activation of NF-kappaB in lymphocytes. Curr Opin Immunol 2004; 16: 374–381
   PubMed Web of Science ®Google Scholar
• Lin X, Wang D. The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling. Semin Immunol 2004; 16: 429–435
   PubMedGoogle Scholar
• Mueller A, O'Rourke J, Grimm J, Guillemin K, Dixon M F, Lee A, et al. Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Proc Natl Acad Sci USA 2003; 100: 1292–1297
   PubMed Web of Science ®Google Scholar
• Barth T F, Barth C A, Kestler H A, Michl P, Weniger M A, Buchholz M, et al. Transcriptional profiling suggests that secondary and primary large B-cell lymphomas of the gastrointestinal (GI) tract are blastic variants of GI marginal zone lymphoma. J Pathol 2007; 211: 305–313
   PubMed Web of Science ®Google Scholar
• Lucas P C, Yonezumi M, Inohara N, McAllister-Lucas M, Abazeed M E, Chen F F, et al. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappa B signaling pathway. J Biol Chem 2001; 276: 19012–19019
   PubMed Web of Science ®Google Scholar
• Akagi T, Motegi M, Tamura A, Suzuki R, Hosokawa Y, Suzuki H, et al. A novel gene, MALT 1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 1999; 18: 5785–5794
   PubMed Web of Science ®Google Scholar
• Shinohara H, Yasuda T, Aiba Y, Sanjo H, Hamadate M, Watarai H, et al. PKC beta regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1. J Exp Med. 2005; 202: 1423–1431
   Google Scholar
• Tian M T, Gonzalez G, Scheer B, DeFranco A L. Bcl10 can promote survival of antigen-stimulated B lymphocytes. Blood 2005; 106: 2105–2112
   PubMed Web of Science ®Google Scholar
• Thome M. CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat Rev Immunol 2004; 4: 348–359
   PubMed Web of Science ®Google Scholar
• Hikida M, Johmura S, Hashimoto A, Takezaki M, Kurosaki T. Coupling between B cell receptor and phospholipase C-gamma2 is essential for mature B cell development. J Exp Med 2003; 198: 581–589
   PubMed Web of Science ®Google Scholar
• Nakagawa M, Seto M, Hosokawa Y. Molecular pathogenesis of MALT lymphoma: two signaling pathways underlying the antiapoptotic effect of API2-MALT1 fusion protein. Leukemia 2006; 20: 929–936
   PubMed Web of Science ®Google Scholar
• Marafioti T, Pozzobon M, Hansmann M L, Delsol G, Pileri S A, Mason D Y. Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease. Blood 2004; 103: 188–193
   PubMed Web of Science ®Google Scholar
• Pozzobon M, Marafioti T, Hansmann M L, Natkunam Y, Mason D Y. Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples. Br J Haematol 2004; 124: 519–533
   PubMed Web of Science ®Google Scholar
• Marafioti T, Pozzobon M, Hansmann M L, Gaulard P, Barth T F, Copie-Bergman C, et al. Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma. Leukemia 2005; 19: 856–861
   PubMed Web of Science ®Google Scholar
• Boise L H, Gonzalez-Garcia M, Postema C E, Ding L, Lindsten T, Turka L A, et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74: 597–608
   PubMed Web of Science ®Google Scholar
• Miyashita T, Krajewski S, Krajewska M, Wang H G, Lin H K, Liebermann D A, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994; 9: 1799–1805
   PubMed Web of Science ®Google Scholar
• Barrena S, Almeida J, Yunta M, Lopez A, Fernandez-Mosteirin N, Giralt M, et al. Aberrant expression of tetraspanin molecules in B-cell chronic lymphoproliferative disorders and its correlation with normal B-cell maturation. Leukemia 2005; 19: 1376–1383
   PubMed Web of Science ®Google Scholar
• Legler D F, Loetscher M, Roos R S, Clark-Lewis I, Baggiolini M, Moser B. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med. 1998; 187: 655–660
   Google Scholar
• Ansel K M, Ngo V N, Hyman P L, Luther S A, Forster R, Sedgwick J D, et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 2000; 406: 309–314
   PubMed Web of Science ®Google Scholar
• Husson H, Freedman A S, Cardoso A A, Schultze J, Munoz O, Strola G, et al. CXCL13 (BCA-1) is produced by follicular lymphoma cells: role in the accumulation of malignant B cells. Br J Haematol 2002; 119: 492–495
   PubMed Web of Science ®Google Scholar
• Mazzucchelli L, Blaser A, Kappeler A, Scharli P, Laissue J A, Baggiolini M, et al. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J Clin Invest 1999; 104: R49–R54
   Google Scholar
• Muzio M, Bosisio D, Polentarutti N, D'Amico G, Stoppacciaro A, Mancinelli R, et al. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 2000; 164: 5998–6004
   PubMed Web of Science ®Google Scholar
• Sagaert X, De Wolf-Peeters C, Noels H, Baens M. The pathogenesis of MALT lymphomas: where do we stand? Leukemia. 2007; 21: 389–396
   Google Scholar
• Fisher S G, Fisher R I. The emerging concept of antigen-driven lymphomas: epidemiology and treatment implications. Curr Opin Oncol 2006; 18: 417–424
   PubMed Web of Science ®Google Scholar
• Matteucci C, Galieni P, Leoncini L, Lazzi S, Lauria F, Polito E, et al. Typical genomic imbalances in primary MALT lymphoma of the orbit. J Pathol 2003; 200: 656–660
   PubMed Web of Science ®Google Scholar
• Dierlamm J, Pittaluga S, Wlodarska I, Stul M, Thomas J, Boogaerts M, et al. Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. Blood 1996; 87: 299–307
   PubMed Web of Science ®Google Scholar